PG
43
3
KO
46
5
M
59
-2
AMP
73
-3
COF
65
-3
AMAT
49
-6
EL
56
4
GILD
47
-5
IP
31
-6
HBAN
85
-2
MSFT
40
-3
CVX
25
-4
CPB
39
2
GOOG
73
14
FCX
74
-2
UHS
60
-3
XYL
41
-8
RF
74
-2
FLS
53
-15
PFE
39
-2
PG
43
3
KO
46
5
M
59
-2
AMP
73
-3
COF
65
-3
AMAT
49
-6
EL
56
4
GILD
47
-5
IP
31
-6
HBAN
85
-2
MSFT
40
-3
CVX
25
-4
CPB
39
2
GOOG
73
14
FCX
74
-2
UHS
60
-3
XYL
41
-8
RF
74
-2
FLS
53
-15
PFE
39
-2
Financhill
Back

Sprott Lithium Miners ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
44

LITP
Sprott Lithium Miners ETF

Last Price:
$12.15
Seasonality Move:
-18.11%
Buy
77

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.65
Seasonality Move:
9.28%
Sell
44
Sprott Lithium Miners ETF (LITP) is a Sell

Is Sprott Lithium Miners ETF a Buy, Sell or Hold?

  • The current Sprott Lithium Miners ETF [LITP] share price is $11.97. The Score for LITP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • LITP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.65. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LITP Stock Price Chart

What is Sprott Lithium Miners ETF's stock price today?

  • The Sprott Lithium Miners ETF share price today is $11.97
    The current trend is moderately bullish and LITP is experiencing selling pressure, which indicates risk of future bearish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

LITP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.48 Buy
Relative Strength Index (14 RSI): 56.46 Buy
Chaikin Money Flow: -54365 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.81 - 12.31) Buy
Bollinger Bands (100): (7.65 - 10.99) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 21.57 Buy
Relative Strength Index (14 RSI): 86.06 Buy
Chaikin Money Flow: 367727 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (151.4 - 242.46) Buy
Bollinger Bands (100): (51.44 - 167.06) Buy

LITP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.05 Sell
20-day SMA: 11.88 Buy
50-day SMA: 10.76 Buy
200-day SMA: 7.6 Buy
8-day EMA: 12.12 Sell
20-day EMA: 11.72 Buy
50-day EMA: 10.78 Buy
200-day EMA: 8.66 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.33 Buy
20-day SMA: 219.69 Buy
50-day SMA: 150.04 Buy
200-day SMA: 68.84 Buy
8-day EMA: 219.45 Buy
20-day EMA: 204.15 Buy
50-day EMA: 162.92 Buy
200-day EMA: 88.08 Buy

Sprott Lithium Miners ETF Earnings Growth & LITP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Sprott Lithium Miners ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):